A B S T R A C T A primary bovine adrenocortical cell culture system responsive to physiological concentrations of ACTH has been established. When added to cultures, ACTH inhibited DNA synthesis and cell division over the same concentration range required for stimulation of fluorogenic steroid production (0.01-10 nM). With chronic exposure to ACTH, cells became desensitized to the growth inhibitory effects of ACTH. Though cell growth was initially completely inhibited by ACTH, cells ultimately began to grow in its continued presence. The lag time to initiation of cell growth, the rate of growth, and the final density achieved depended on the ACTH concentration. Desensitization to ACTH1_39 was not induced by monobutyryl cyclic AMP nor by ACTH11-24. Specificity of desensitization was apparent because cells which had become desensitized to ACTH1_39 remained fully responsive to monobutyryl cyclic AMP, prostaglandin E1, and cholera toxin. Though the effects of ACTH on cell growth were readily reversible upon hormone removal, the desensitized response to readdition of ACTH persisted for at least 8 h.
A B S T R A C T A primary bovine adrenocortical cell culture system responsive to physiological concentrations of ACTH has been established. When added to cultures, ACTH inhibited DNA synthesis and cell division over the same concentration range required for stimulation of fluorogenic steroid production (0.01-10 nM). With chronic exposure to ACTH, cells became desensitized to the growth inhibitory effects of ACTH. Though cell growth was initially completely inhibited by ACTH, cells ultimately began to grow in its continued presence. The lag time to initiation of cell growth, the rate of growth, and the final density achieved depended on the ACTH concentration. Desensitization to ACTH1_39 was not induced by monobutyryl cyclic AMP nor by ACTH11-24. Specificity of desensitization was apparent because cells which had become desensitized to ACTH1_39 remained fully responsive to monobutyryl cyclic AMP, prostaglandin E1, and cholera toxin. Though the effects of ACTH on cell growth were readily reversible upon hormone removal, the desensitized response to readdition of ACTH persisted for at least 8 h. Fibroblast growth factor (FGF) stimulated both the growth rate and saturation density achieved. FGF did not alter the growth inhibitory effects of ACTH nor the reduced growth rate observed in desensitized cells maintained in ACTH. However, FGF greatly increased the saturation density achieved by cultures maintained with ACTH.
INTRODUCTION
Experiments with cultured adrenocortical cells derived from either normal tissue (1, 2) or an adrenal tumor (Y-1 cells) (3) have established that the direct action of ACTH' on the adrenocortical cell is antimitotic. It has therefore been suggested that the stimulatory action of ACTH on adrenal cell division in vivo may be indirect (4, 5) , possibly being mediated by a growth factor. One of the known growth factors, fibroblast growth factor (FGF) has been demonstrated to be mitogenic for both normal (4) and tumor (6) adrenocortical cells in culture. If such a growth factor acts in vivo, its effect would be opposed by the direct anti-growth action of ACTH. This activity of ACTH has been shown, in studies in cultured Y-1 cells, to be most pronounced in the inhibition of DNA synthesis, with RNA and protein synthesis being little affected (5) . Because RNA and protein synthesis are stimulated by serum growth factors and the steroidogenic pathway by ACTH, the result is a hypertrophied hyperfunctional adrenocortical cell (5, 7) . This correlates well with the action of ACTH 1Abbreviations used in this paper: ACTH (8, 9) . Nevertheless, adrenal cell division does occur in vivo in the presence of elevated levels of ACTH (9) (10) (11) (12) , particularly under such conditions as adrenal regeneration (13) . We have therefore investigated in detail the effects of ACTH on the proliferation of normal adult bovine adrenocortical cells in monolayer culture, studying in particular the results of prolonged ACTH treatment and the interaction of ACTH with the one known mitogenic hormone for the adrenal cell, FGF.
METHODS
Preparation of cultures. The method of preparing a suspension of adrenocortical cells from bovine adrenal glands has been previously described (4) . 20 ml of cell suspension was obtained per gland. Additional fetal calf serum was added to make the total serum concentration 20%, and dimethyl sulfoxide (Mallinckrodt Inc., St. Louis, Mo.) added to give a 5% solution. The cell suspension was then divided into 2-ml aliquots which were placed in vials and frozen in liquid nitrogen. Cells remained viable for at least 6 mo and multiple experiments could be performed with the same cell preparation. Vials were subsequently recovered from liquid nitrogen as required, unfrozen and diluted in an appropriate volume of Coon and Weiss' modification (14) 
RESULTS
Acute responsiveness to ACTH. In the bovine adrenocortical cell system, responsiveness to physiological concentrations of ACTH was demonstrated by dose-response curves for ACTH which indicated halfmaximal fluorogenic steroid production at approximately 0.5 nM ACTH (Fig. 1) . Similar dose-response curves were obtained at the initiation of cell growth (day 1), during log growth (day 4), and as cells entered the stage of density-dependent inhibition ofcell growth (day 6) (see Fig. 4 ). Previous When the adrenal cells which had grown to confluence were subcultured, the steroidogenic capacity per cell was found to be equal to that of freshly prepared cultures whether the subcultured cells had previously been maintained with ACTH or in its absence (Fig. 2 ). In this experiment cells which had grown to confluence in the absence or presence of 10 nM ACTH were subcultured and grown without ACTH to a density of 105 cells/plate. Cholera toxin, which is a potent stimulator of steroidogenesis in cultured adrenocortical cells (20) , was added to assess maximal steroidogenic capacity independently of any alterations in ACTH sensitivity due to pretreatment. A progressive increase in steroidogenic capacity was seen in both freshly plated and subcultured cells; the same maximum rate of steroid production per cell was reached by day 4. The increasing steroidogenic capacity with prolonged cholera toxin treatment resembles that seen with prolonged ACTH treatment in other adrenal cell culture systems (7, (21) (22) (23) 5 ). By autoradiography, ACTH was shown previously to inhibit DNA synthesis in >98% of the cells (4) .
When ACTH-treated cells were examined by flow microfluorometry, a predominant G1 arrest was observed. As shown in Fig. 3 (5, 7) .
Treatment of cultures with aminoglutethimide, an inhibitor of the conversion of cholesterol to pregnenolone (24) , reduced the ACTH and monobutyryl cyclic AMP (cAMP)-stimulated level of steroid production to the nonstimulated level seen in the absence of aminoglutethimide (Table I) . Under these conditions, ACTH and monobutyryl cAMP continued to reduce [3H]thymidine incorporation into DNA to the same extent as in the non-aminoglutethimide-treated cultures. ACTH does not appear to inhibit adrenal cell proliferation through its stimulation of steroidogenesis but by raising the intracellular concentration of cAMP (3) . The cultured cells behaved therefore as a single population of adrenocortical cells with respect to cell division, responsiveness to ACTH, and retention of steroidogenic capacity. The pattern of a lag followed by exponential growth indicated that the cells must undergo considerable desensitization to the original inhibitory effect of ACTH (Fig. 1) (Fig. 2 ). Effect of ACTH11-24 and monobutyryl cAMP on cell growth. When a high concentration of ACTHl-39 (10 nM) was added to cultures during exponential growth, an approximate doubling of cell number occurred, followed by cessation of growth within 24 h (Fig. 6 ). This response correlates with inhibition of
[3Hl]thymidine incorporation into DNA (Fig. 1) , and with the G, point of growth arrest (Fig. 3) .
In contrast, when the adrenocortical cells were maintained in the presence of a high concentration (10 ,uM) of an ACTH fragment (ACTH11-24), no significant effect on cell growth occurred (Fig. 6) . This ACTH11_24 fragment acts as a competitive inhibitor of ACTHI_39 by binding to ACTH receptor sites but lacks the amino terminal portion required for biological activity (26, 27) .
Monobutyryl cAMP stimulates steroidogenesis and inhibits [3H]thymidine incorporation into DNA in the bovine adrenocortical cell system. When cells were maintained with a concentration of monobutyryl cAMP (1 mM), equivalent to 10 nM ACTH in inhibiting [3H]thymidine incorporation, cell growth did not occur (Fig. 6 ). This persistent growth inhibition contrasts with the resistance to the growth inhibitory effects of ACTHl_39 which developed over this time period.
Effect of desensitization to ACTH on responsiveness to monobutyryl cAMP, prostaglandin E1, and cholera toxin. The incorporation of [3H]thymidine into DNA in growing bovine adrenocortical cells is inhibited by monobutyryl cAMP, prostaglandin El, and cholera toxin (Fig. 7) . ACTH, prostaglandin El, and cholera toxin have all been reported to elevate cAMP levels in adrenocortical cells (28) (29) (30) . When cells which have become desensitized to the growth inhibitory effects of 10 nM ACTH were tested for sensitivity to monobutyryl cAMP, prostaglandin El, and cholera toxin, sensitivity equivalent to control cultures was noted (Fig. 7) . Though initial [3H]thymidine incorporation over a 4-h period was lower, consistent with the prolonged average cell cycle time of ACTH-treated cultures, no change in the dose-response curves occurred indicating that desensitization to ACTH did not cause desensitization to these other substances. [3H]thymidine incorporation and cell growth (4) did not affect the 50% effective dose of ACTH required for inhibition of DNA synthesis (Fig. 8) .
Reversibility of growth inhibition due to ACTH. When ACTH is removed from cultures which have become desensitized, i.e., have entered the exponential phase of cell growth in the presence of ACTH, the rate of growth increases and a higher saturation plateau is achieved (Fig. 9) .
Though the rate of cell growth and saturation density increase when ACTH is removed, cells remain resistant to subsequently added ACTH. When cultures which had become desensitized to 10 nM ACTH and were growing at a reduced rate in its presence were washed and incubated for an additional period with 0.01-100 nM ACTH, there was much less inhibition of [3H]thymidine incorporation at any dose tested compared to nontreated cultures (Fig. 10) . The flattened dose-response curve persisted when cells were incubated for 8 h in ACTH-free medium before subsequent addition of ACTH. The increased rate of cell growth upon ACTH removal suggests that the insensitivity to ACTH is not due to ACTH from the original exposure remaining bound to receptors. Bound ACTH is released from receptors with a half-life of 3 min at 370 C (27) . Initial exposure to 10 nM ACTH for 20 
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P. J. Hornsby and G. N. Gill min, a time sufficient to saturate ACTH receptors, followed by normal washing had no effect on the subsequent response to ACTH; i.e., cells remained sensitive to ACTH giving an identical response to the control curve shown in Fig. 10 . Pretreatment for 6 days with a lower concentration of ACTH (0.1 nM) resulted in a dose-response curve which on subsequent incubation with 0.01-100 nM ACTH showed partial desensitization. This dose-response curve was intermediate between that seen with 10 nM ACTH and no pretreatment. As seen in Fig. 10 , desensitization results in a decrease in maximum responsiveness to subsequent ACTH. Interaction of ACTH and FGF on proliferation. As previously demonstrated (4) , FGF was effective in promoting the growth of cultured adrenocortical cells especially from low densities and its use resulted in the achievement of higher saturation densities (Fig. 11) .
When saturating concentrations of FGF (100 ng/ml) and ACTH (10 nM) were added together to cultures at each medium change, growth up to about 6 days after plating was not different from cultures treated with 10 nM ACTH alone (Fig. 11) . After initial inhibition by ACTH, desensitization occurred and cells initiated growth at a reduced rate. However, after approximately 6 days, there was a marked difference between FGF treated and nontreated cultures. In the absence of FGF, ACTH-treated cells plateaued at a low density. In the presence of FGF, ACTHtreated cells continued to grow at the reduced rate and achieved a cell density at least 10-fold higher than in its absence. FGF thus appears to have no effect on the initial sensitivity of the cells to ACTH because it does not change the dose-response curve of ACTH inhibition of DNA synthesis (Fig. 8) , nor does it change the lag time to initiation of growth in the presence of ACTH (Fig. 11) . Similarly, FGF failed to alter the reduced growth rate seen in the presence of continuously elevated ACTH levels. The major effect of FGF was to allow continued growth so that significantly higher saturation densities were achieved.
When ACTH was removed from cultures maintained in the presence of FGF, reversibility of ACTH inhibition was again noted (Fig. 11) . The growth rate increased to the rapid rate observed in the presence of FGF alone; this rate exceeded that of cells maintained in the presence of FGF and ACTH.
The present results indicate that in cultured normal bovine adrenocortical cells, the continuous presence of high levels of ACTH did not prevent considerable division of adrenal cells from occurring, despite a marked initial inhibition of DNA synthesis. Cells growing in the presence of ACTH retain their adrenalspecific properties and also remain responsive to FGF which causes the cultures to achieve far higher cell densities than is possible in the absence of FGF. If culture conditions reflect in vivo conditions, the adrenal gland could well achieve a long-term increase in cell number, even if ACTH has a direct antimitotic action in vivo and stimulates growth of the adrenal by an indirect mechanism as we have postulated (4, 5, 7) . Most of the increase in DNA content in vivo is a late effect of increasing the circulating level of ACTH (9) . It may be that in vivo as in culture there is an initial period when ACTH is strongly inhibitory to DNA synthesis, resulting in cellular hypertrophy (5, 8) (26, 27) . Because ACTH11-24 lacks the active site of the ACTH molecule (present in positions 1-10) (38) , it has Ino agonist activity. Pretreatment with this fragment at a high concentration had no desensitizing action. Mere receptor occupancy does not appear sufficient for desensitization; elevated cAMP levels are also insufficient for development of desensitization. Similar specificity for development of desensitization to catecholamines and LH has been reported (37, 39 (4) . The action of FGF on migration, saturation density, and growth of cells from very low densities (4) seems to be separate from actual control of growth rate. Whether these phenomena are all expressions of one common initial action of FGF remains to be studied.
It is also unknown at this time whether FGF or an FGF-like molecule is of importance in vivo in stimulating adrenal growth. Some specificity for FGF exists because epidermal growth factor does not affect adrenocortical cell growth (4). An FGF-like molecule has been isolated from the pituitary and shown to be effective in stimulating the growth of ovarian cells in culture (40) . The possibility that such a factor may act on adrenocortical cells in vivo is supported by a number of experiments demonstrating growth in response to factors other than ACTH. Growth hormone has been implicated as an adrenal growth stimulator (41) and an adrenal weight-maintaining factor distinct from ACTH was demonstrated in patients with Cushing's syndrome (42) . In addition, neural stimulation of the adrenal results in growth by an ACTH-independent mechanism (43, 44) .
Though ACTH inhibits DNA synthesis acutely, it does not block serum-induced cellular hypertrophy (5); under these conditions, ACTH induces the steroidogenic capacity of the cell (7) . This results in a hypertrophied adrenocortical cell with increased steroidogenic potential. With 
